One biological asset - Moringa - engineered into validated products across human health, agriculture, and nutrition. Most solutions fight one front. Ours fight both.
For thousands of years Moringa has been valued as medicine, as a soil and water treatment, and as one of the most nutrient-dense foods known. Yet that traditional knowledge has rarely been characterized, standardized, and validated to the standard regulated markets demand.
MGI closes that gap. The same plant, science, and supply chain serve human health, agricultural solutions, and functional foods, so every advance in research, extraction, or validation compounds across the portfolio.
Nutrient-dense, fast-growing, and climate-resilient - sourced through a farmer-first Zambian supply chain. One crop feeds every division, lowering cost, reducing risk, and reinforcing a single brand story from farm to finished good.
We characterize, standardize, and validate Moringa-based products for human health, agriculture, and nutrition, then move them through pilots toward certified, regulated, consumer-ready products.
A problem is rarely a single-front event. In the body, the ecosystem, or the diet, difficulty arises from the convergence of a depleted system and an external stressor that exploits it.
Rebuild the underlying base of health: nutrients, soil biology, crop vigor, or everyday nutritional resilience.
Use bioactive clusters and functional proteins to meet the external threat, from disease pressure to contaminants and stress.
Nourish the host and fight the disease through clinically credible, Moringa-based nutraceutical pathways.
Restore the ecosystem and counter the stressor through crop biostimulation, soil health, and water-treatment science.
Nourish the body and support its defenses with whole-leaf nutrition and antioxidant clusters in clean-label products.
Three divisions share one asset, one science base, and one supply chain, making each new product cheaper and less risky to launch.
A founding team that pairs deep bench science with operating and finance discipline - the combination needed to cross from lab to market.
The platform rests on peer-reviewed science across human health, environmental applications, and extraction.
Lab-tested across malaria, cancer, prostate conditions, arthritis, and inflammation, standardized around Moringa bioactive clusters. Lead candidate targets prostate health.
Moringa applications across crop biostimulation, regenerative agroforestry, and seed-protein water purification, including sediment, pathogen, and microplastic removal pathways.
Whole-leaf nutrition characterized for clean-label functional products, drawing on the same traceable supply and the same standardized Moringa science base.
Every product advances through the same sequence. Each step is a fundable milestone, so capital is deployed against demonstrated validation rather than speculative scale-up.
A drug may ignore the malnourished patient, and a fertilizer may ignore soil degradation. Moringa can address both the system and the stressor.
Vertical control from farm to formulation creates quality we can prove and margins raw-material buyers cannot easily match.
A farmer-first Zambian supply chain supports quality, resilience, and inclusive growth from the start.
Demand is rising for evidence-backed, clean-label, nature-based solutions across wellness, food, and agriculture.
Moringa's drought tolerance and rapid biomass cycling make it a practical crop for climate-stressed regions.
Learnings in extraction, characterization, field data, and clinical data compound across the whole portfolio.
Interested in investor conversations, pilot partnerships, research collaboration, or supply-chain partnerships? Send us a message, or email us directly at info@moringagi.com.